First Case of Toxoplasmosis Following Small Bowel Transplantation and Systematic Review of Tissue-Invasive Toxoplasmosis Following Noncardiac Solid Organ Transplantation
- 1 February 2006
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 81 (3), 408-417
- https://doi.org/10.1097/01.tp.0000188183.49025.d5
Abstract
Toxoplasmosis prophylaxis is standard following heart and heart lung transplantation, when an increased risk of allograft transmitted Toxoplasma is well-recognized. In contrast, prophylaxis and routine serologic evaluation of donors and recipients for Toxoplasma in noncardiac solid organ transplantation (SOT) is not recommended. We report the first case of disseminated toxoplasmosis following small bowel transplantation, presumably transmitted via the transplanted intestine and systematically review reported cases of toxoplasmosis in noncardiac SOT recipients to determine if current guidelines should be reconsidered. Systematic MEDLINE review was performed for tissue invasive toxoplasmosis in noncardiac SOT recipients and analysis of clinical features, serologic status, and treatment regimens with respect to mortality. Fifty-two cases of toxoplasmosis in noncardiac SOT recipients were identified. Eighty-six percent developed disease within 90 days of transplantation. Presentation was nonspecific and consisted of fever (77%), respiratory distress (29%), neurologic manifestations (29%), and bone marrow suppression (26%). Multivariate analyses demonstrated that localized disease (odds ratio [OR]=37.36, 95% CI 1.85-754.85), treatment received (OR=1.814, 95% CI 1.193-3.480) and donor and recipient serostatus (OR=1.39, 95% CI 1.068-1.815) were predictors of survival. High-risk recipients (donor seropositive/recipient seronegative) developed disease earlier (16 days vs. 31 days P=0.002) and were less likely to survive (OR=0.14, 95% CI 0.03-0.69) than standard-risk recipients. Toxoplasmosis is recognized following noncardiac SOT. Reduction of morbidity and mortality necessitates knowledge of donor and recipient Toxoplasma serostatus, prophylaxis, early diagnosis, and treatment. The findings support a reconsideration of pretransplantation evaluation and prophylaxis strategies in SOT recipients.Keywords
This publication has 55 references indexed in Scilit:
- Toxoplasmosis after Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2000
- Toxoplasma gondii Pneumonia in a Pancreas Transplant PatientSouthern Medical Journal, 2000
- Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2000
- Disseminated Toxoplasmosis After Liver Transplantation: Case Report and ReviewClinical Infectious Diseases, 1998
- Toxoplasmosis in heart transplant recipientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Perioperative respiratory management with fiberoptic bronchoscopy in pediatric living-related liver transplantationSurgery, 1996
- Chorioretinitis Following Liver Transplantation: Detection of Toxoplasma gondii in Aqueous HumorClinical Infectious Diseases, 1996
- AtovaquoneDrugs, 1995
- An opportunity not to be missedThe British Journal of Radiology, 1988
- TOXOPLASMOSIS IN TWO RENAL TRANSPLANT RECIPIENTS FROM A SINGLE DONORTransplantation, 1987